ArticleBMJ neurology open2025
Severe hyperCKaemia and decreased sarcolemmal dysferlin in VRK1-associated distal spinal muscular atrophy: a case report.
Article in BMJ neurology open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Variants in the vaccinia-related kinase 1 (VRK1) gene have been linked to a spectrum of lower motor neuron disorders, typically characterised by distal muscle weakness and atrophy. Homozygous c.961C>T (p.Arg321Cys) is a rare mutation associated with a slowly progressive distal spinal muscular atrophy phenotype, usually presenting with normal or mildly elevated creatine kinase (CK) levels. Case presentation: A 29-year-old man born to consanguineous parents presented with a 2 year history of progressive lower limb weakness. Examination revealed distal lower limb muscle wasting, absent ankle reflexes and brisk knee and upper limb reflexes. CK was elevated at 17 791 IU/L (normal<190). Neurophysiology showed a motor neuropathy with chronic active denervation, and MRI showed fatty atrophy and oedema in lower limb muscles. Muscle biopsies revealed neurogenic atrophy, scattered necrotic myofibres, pseudo-dystrophic changes and reduced sarcolemmal dysferlin. Genetic testing identified a homozygous VRK1 (c.961C>T, p.Arg321Cys) variant. Conclusions: This report expands the VRK1 phenotype to include marked hyperCKaemia. Elevated CK levels are typically associated with inflammatory myopathies, though they can be seen in primary diseases of the motor neurons. A lack of sarcolemmal dysferlin could underlie myofibre sensitivity to minor trauma and cause elevated CK levels in chronic muscle denervation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.